S 3738 · 115th Congress · Health

Hatch-Waxman Integrity Act of 2018

Introduced 2018-12-11· Sponsored by Sen. Hatch, Orrin G. [R-UT]· Senate

Bill Progress

✓
Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2018-12-11)

Plain Language Summary

[AI summary unavailable — showing source text] Hatch-Waxman Integrity Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent a generic drug or biosimilar manufacturer from using a specific review process for challenging pharmaceutical drug or biologic patents.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican
Sen. Tillis, Thomas [R-NC]NC